These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 22555150)

  • 1. Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis.
    Ruggeri A; Michel G; Dalle JH; Caniglia M; Locatelli F; Campos A; de Heredia CD; Mohty M; Hurtado JM; Bierings M; Bittencourt H; Mauad M; Purtill D; Cunha R; Kabbara N; Gluckman E; Labopin M; Peters C; Rocha V
    Leukemia; 2012 Dec; 26(12):2455-61. PubMed ID: 22555150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
    Tucunduva L; Ruggeri A; Sanz G; Furst S; Cornelissen J; Linkesch W; Mannone L; Ribera JM; Veelken H; Yakoub-Agha I; González Valentín ME; Schots R; Arcese W; Montesinos P; Labopin M; Gluckman E; Mohty M; Rocha V
    Br J Haematol; 2014 Sep; 166(5):749-57. PubMed ID: 24961645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
    Bachanova V; Burke MJ; Yohe S; Cao Q; Sandhu K; Singleton TP; Brunstein CG; Wagner JE; Verneris MR; Weisdorf DJ
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):963-8. PubMed ID: 22430088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia.
    Appelbaum FR
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):279-84. PubMed ID: 24309531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
    Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pre-transplant minimal residual disease on outcome of intensified myeloablative cord blood transplant for acute myeloid leukemia in first or second complete remission.
    Zheng C; Zhu X; Tang B; Zhang L; Geng L; Liu H; Sun Z
    Leuk Lymphoma; 2016; 57(6):1398-405. PubMed ID: 26690538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
    Kato K; Yoshimi A; Ito E; Oki K; Hara J; Nagatoshi Y; Kikuchi A; Kobayashi R; Nagamura-Inoue T; Kai S; Azuma H; Takanashi M; Isoyama K; Kato S;
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1814-21. PubMed ID: 21664471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
    Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1350-1358. PubMed ID: 28438676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
    Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Friend BD; Bailey-Olson M; Melton A; Shimano KA; Kharbanda S; Higham C; Winestone LE; Huang J; Stieglitz E; Dvorak CC
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28079. PubMed ID: 31724815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
    Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
    J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
    Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringdén O; Uhlin M; Mattsson J
    Transplantation; 2012 Nov; 94(10):1066-74. PubMed ID: 23076550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
    Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia.
    Hayashi H; Volt F; Sanz J; Petersen E; Dhedin N; Hough R; Milpied N; Angelucci E; Yakoub-Agha I; Michallet M; Michel G; Aljurf M; Kenzey C; Rocha V; Dalle JH; Bader P; Ruggeri A; Gluckman E;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2438-2446. PubMed ID: 31394275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.
    Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA
    Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.